<DOC>
	<DOCNO>NCT01359410</DOCNO>
	<brief_summary>The investigator propose randomize , control trial staple pancreatic transection versus mesh reinforce staple pancreatic transection . For duration study period , participate surgeon utilize standardized staple technique . Either reabsorbable polytrimethylene carbonate mesh ( SEAMGUARD速 ) reabsorbable strip bovine pericardium ( PERI-STRIPS DRY速 ) use reinforce staple pancreatic transection line test group . In order uniform test method , investigator utilize laparoscopic stapling device open laparoscopic procedure uniform staple size ( 4.8mm ) .</brief_summary>
	<brief_title>Reinforced Staple Line Leak Rate Distal Pancreatectomy</brief_title>
	<detailed_description>Pancreatic leak remain significant cause morbidity extra cost follow distal pancreatectomy . Historically , previous attempt reduce leak rate meet limited success . To examine problem investigator propose randomize , control trial staple pancreatic transection versus mesh reinforce staple pancreatic transection . For duration study period , participate surgeon utilize standardized staple technique . Either reabsorbable polytrimethylene carbonate mesh ( SEAMGUARD速 ) reabsorbable strip bovine pericardium ( PERI-STRIPS DRY速 ) use reinforce staple pancreatic transection line test group . In order uniform test method , investigator utilize laparoscopic stapling device open laparoscopic procedure uniform staple size ( 4.8mm ) . A drain place leave upper quadrant time resection . Drainage pancreatic resection bed widely accept remain current standard care .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Participants must 18 year older able give consent . Any patient undergoing distal pancreatectomy , laparoscopic open , eligible randomization . No exclusion provide primary diagnosis . In event patient undergo plan resection another organ organ possibility distal pancreatic resection ( i.e . colectomy , hepatectomy , gastrectomy , nephrectomy ) , patient still eligible inclusion study . We expect patient randomize resect ( ie metastasis identify ) . A patient may staple use study device technical reason ( ie stapler fit ) . The data analyze intenttotreatment approach . None specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Pancreas adenocarcinoma</keyword>
	<keyword>Precancerous lesion pancreas ( mucinous cystic neoplasm , IPMN )</keyword>
	<keyword>Pancreas neuroendocrine cancer</keyword>
</DOC>